For instance, the loss of IFNGR independently predicts the poor prognosis of ovarian cancer patients and might be responsible for the limited success in the outcome of IFN-γ treatment of ovarian cancer [146]. This evidence concerns the gene IFNGR1 and ovarian carcinoma.